Submissions

Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in Microsoft Word file format.
  • Where available, URLs for the references have been provided.
  • The text is double-spaced; uses a 10-point Times New Roman font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.

Author Guidelines

Manuscripts should contain original data which were not previously published or are being considered for publication elsewhere. Authors are required to submit the manuscript along with all these documents:

  • Copyright form,
  • submission form,
  • corresponding author form

These forms are available on the website https://www.bnchospital.edu.np of the journal.

Manuscript Submission:

  • Cover letter: addressing editor-in-chief of the journal for publication
  • Manuscript: Research Article/Case Review/Original Research/Review Article file,
  • Figure/Table/Graph/Flowchart (add descriptive legends) in MS Word file.

With all these documents, authors are required to send the attachments to the following address
bncjournal2021@gmail.com or editormjen@gmail.com

Components of Manuscript

Overall outline:
Microsoft Word 97-2003 or higher document file must be used to submit a manuscript. The text must be double-spaced with 1’’ margins and justified paragraph margins. The word format recommended is Times New Roman with 10-point text every page should be numbered.

Components:
1. TITLE PAGE:
Title:
Should appear at the top of the first page. The title must clearly state what the article is about. Name and affiliation: Full name of each author (first name, middle initial, and last name) followed by each author's highest academic degree(s) and designation. Name of department(s) and institution(s) along with complete address such as city, state, and country with which each author is affiliated and to which work should be attributed. Corresponding Address: Name, address, telephone number, fax number, and e-mail of the corresponding author.

Author Names: Do not include author names in the manuscript in order to preserve anonymity during the review process. Authors' names need to be included only on the Title page.

2. ABSTRACT:
Includes Backgrounds, Methods, Results, and conclusions all articles must include a structured abstract of approximately 250 words only including material appearing in the main body of the manuscript. Authors are required to indicate the Relevance in a statement of clinical significance within the abstract of the manuscript as well as at the end of the main body of the text.

Keywords: A list of three to six keywords contained in the article must be listed below the abstract. A minimum of three and a maximum of six keywords are required as indexed in MeSH – NCBL.

3. MANUSCRIPT:
The following formats for different types of articles submitted are required.

Original Articles: Introduction, Methods, Results, Discussion, Conclusion, Acknowledgment, References
Review Articles: Introduction, Results, Discussion, Conclusion, Acknowledgements, References
Case Reports: Introduction, Case Description, Discussion, Conclusion, References
Technical Notes: Introduction, Technique, Discussion, Conclusion, References

INTRODUCTION
This should clearly state the purpose of the study and identify what issues are going to be addressed.

METHODS
All relevant attributes of the material forming the subject of the research should be provided. Experimental methodology should be concisely and appropriately explained. Commercially produced materials, devices, software, etc. must be followed by name of the manufacturer and location. Statistical methods should be clearly specified. Manuscripts reporting human studies should include evidence that the study was ethically conducted in accordance with the Declaration of Helsinki.

RESULTS
This section should clearly state the results in simple language use of tables, illustrations and graphs is encouraged but data in table or illustration form should be referenced in the text and should not be repeated. Statistical tests should be clearly defined and statistical significance should be shown.

DISCUSSION
The discussion should focus on the relevant findings of the study with its observations related to other similar studies in a sequential manner. The Discussion should also summarize the data and conclusions at the end which should be the aiming objectives of the study and should clearly state whether or not the objective was achieved. Limitations of the study should also be mentioned.

CONCLUSION
One or a few sentences of the conclusion of the whole article is written here.

ACKNOWLEDGMENTS
In this section, the author can acknowledge the source of funding for the research. An additional acknowledgment of support provided by other individuals, organizations, and institutions whose names cannot be stated in authorship can be mentioned here.

Manufacturer Name
Please provide the name of the manufacturer with its complete city and country name of all products used in the research.

Patient Consent
The author has to provide a signed consent of the patient whenever photographs/figures of a patient showing identification are used.

REFERENCES
The bibliography should list references in order of their appearance in the text (not alphabetically) and should follow PubMed Central guidelines along with Vancouver Style. The examples of the references have been mentioned below:

Journal

  1. MC Dermott MT, Ridgway EC. (2001) The diagnosis and treatment of hypothyroidism in: Cooper DS, ed. Practical management of thyroid disorders. New York: Marcel Dekker, Inc; 135-86
  2. Hollowell JG Staehling NW, Flanders WD, et al (2002) Sarum TSH, T4 and thyroid antibodies in United States population (1988 to 1994): National Health Examination Survey (NHAES III) J. Clin EndocrinolMetab:87:489- 499.
  3. Laurence MD, Carole AS. (2002) Laboratory support for diagnosis and monitoring of thyroid disease. Washington (DC): National Academy of Clinical Biochemistry (NACB): 125

Abstract: Hoyme HE, Jones KL, Dixon SD, Jewett T, Hanson JW, Robinson LK, Small ME, Allanson J. Maternal cocaine use and fetal vascular disruption [abstract]. Am J Hum Genet 1988;43(3 Suppl):A56.

Authored Book: Ohlsen, Merle M.; Horne, Arthur M.; Lowe, Charles F. Group counseling. New York: Holt, Rinehart, and Winston; 1988. 416 p.

Article or Chapter in an Edited Book: Anderson, Robert J.; Schrier, Robert W. Acute renal failure. In: Braunswald, Eugene; Isselbacher, Kurt J.; Petersdorf, Robert G., et al., editors. Harrison's principles of internal medicine. 11th ed. New York: McGraw-Hill; 1987. p. 1149-1155.

Article in an Edited Book with Volume: Merritt, Christopher RB. Breast imaging techniques. In: Putnam, Charles E.; Ravin, Carl E., editors. Textbook of diagnostic imaging. Vol. 3. Philadelphia: Saunders; 1988. p. 2118-2120.

Monograph: Lawrence, Ruth A. A review of the medical benefits and contraindications to breastfeeding in the United States [Internet]. Arlington (VA): National Center for Education in Maternal and Child Health; 1997 Oct [cited 2000 Apr 24]. p. 40. Available from: https://www.bnchospital.edu.np

Place the number of references at the end of the sentence as a superscript to which the reference is related. Use commas to separate multiple reference numbers. For example:
"Bond strength of composite resin to dentin is influenced by the presence of a smear layer.4, 15

If more than one reference is contained in a sentence, then number the reference immediately following the text that refers to the reference. For example:
"Bailey1 found that 46% showed signs of metastasis while Varner3 found only 28%."

FIGURES AND LEGENDS
Photographs must be in color; in focus, free of distracting artifacts, and consistent in exposure. Place any required labels or arrows on images prior to uploading. Images must be clearly visible. Substantially, larger images must be avoided to prevent file transmission and electronic manuscript processing errors. Radiographs, drawings, and graphs can be in black and white but color images are preferred.

File names for images must be clearly labeled according to the order in which they appear, (Fig. 1, Fig. 02, and Figs 1 and 2 or Figs 1-S and so on in brackets and in running sentences, it should be spelt out as Figure 1). Images can only be submitted built-in MS Word file with figure legends after each figure.

TABLES
Tables are placed in numerical order at the end of the manuscript following the list of figures.

Copyright
The articles published in this journal are Completely free, provided they follow the norms of copyright as per the Creative Commons Attribution-Non-commercial 4.0 International License. This allows use, distribution, and reproduction in any medium provided the original work is properly cited and is not used for commercial purposes.

REVIEW PROCESS
The article once submitted will undergo a thorough plagiarism check. After this, it will undergo editorial review within one week. Following this it will then be sent for peer review, which takes 2-4 weeks and the authors will receive an email from the Editor stating the final decision of the manuscript.

TYPES OF SUBMISSIONS ACCEPTED
All types of submissions/papers should follow a standard format as described in the above "Manuscript Component" section.

Editorial: Usually provide commentary and analysis concerning an article in the issue of the Journal in which they appear. They may include figures and tables. The editorials would be limited to 1000 words with up to 10 references.

Original Articles: Reports of original clinical and basic research of interest to neurosurgery and allied subjects are accepted. Randomly controlled trial intervention studies, studies of screening and diagnostic tests, outcome studies, cost-effectiveness analysis, case-control series, and surveys with a reasonably high response rate. The text would be limited to 3000-5000 words, with an abstract of 250 words.

Review article: An article review is both a summary and an evaluation of another writer's article. They would cover a contemporary topic and would generally be wide-ranging overviews of a field of research. The reviews and clinical debates will be subject to the standard review process. The minimum word length would be 3000 and the maximum would be 5000 words.

Case Study: The Journal encourages the submission of case reports that highlight practical diagnostic and/or management considerations. The format of these papers should follow that described in the "Manuscript Components" section below. Identifying information within written descriptions, photographs, or pedigrees should not be given.

Case Series: Case-series is a descriptive study design and as the name suggests, it is just a series of cases of any particular disease or disease discrepancy that one might observe in one's clinical practice, etc.

Letters to the Editor: The Journal accepts Letters to the Editor that raises some issues related to recently published articles in the Medical Journal of Eastern Nepal. The letter should not exceed (1000 words)| of text and 10 references.

ACCEPTANCE POLICIES
Review Policy
The journal follows a double-blind review process, where both the reviewer and author remain anonymous throughout the process.

Plagiarism
The authors are strictly advised not to indulge in any form of plagiarism. If the content is found to be plagiarized, the Editor and the journal committee will take serious action in this regard and the author will be responsible for the entire manuscript.

Changes to Authorship
The order, addition, or deletion of author names will not be changed after the submission of the article.

Conflict of interest
All authors are requested to disclose any actual or potential conflict of interest including any Financial, personal or other relationships with other people or organizations that could inappropriately influence, or be perceived to influence, their work.

Role of the funding source
Financial support for the conduct of the research and/or preparation of the article should be briefly described with the role of the sponsor(s). If the funding source(s) had no such involvement then should be stated as none.

Processing Charges
There are no processing charges for the publication of an article in the journal.

Privacy Statement

Nepal Journals Online (NepJOL) is a member of the Ubiquity Partner Network coordinated by Ubiquity Press. According to the EU definitions, NepJOL is the data controller, and Ubiquity Press are the service providers and data processors. Ubiquity Press provide the technical platform and some publishing services to NepJOL and operate under the principle of data minimisation where only the minimal amount of personal data that is required to carry out a task is obtained.

More information on the type of data that is required can be found in Ubiquity Press’ privacy policy below.

Ubiquity Press Privacy Policy

We take seriously our duty to process your personal data in a fair and transparent way. We collect and manage user data according to the following Privacy Policy. This document is part of our Terms of Service, and by using the press portal, affiliated journals, book, conference and repository websites (the “Websites”), you agree to the terms of this Privacy Policy and the Terms of Service. Please read the Terms of Service in their entirety, and refer to those for definitions and contacts.

What type of personal data do we handle?

There are four main categories of personal data stored by our journal platform, our press platform, and our book management system; Website User data, Author data, Reviewer data and Editor data.

The minimum personal data that are stored are:

  • full name
  • email address
  • affiliation (department, and institution)
  • country of residence

Optionally, the user can provide:

  • salutation
  • gender
  • associated URL
  • phone number
  • fax number
  • reviewing interests
  • mailing address
  • ORCiD
  • a short biography
  • interests
  • Twitter profile
  • LinkedIn profile
  • ImpactStory profile
  • profile picture

The data subjects have complete control of this data through their profile, and can request for it to be removed by contacting info@ubiquitypress.com

What do we do to keep that data secure?

We regularly backup our databases, and we use reliable cloud service providers (Amazon, Google Cloud, Linode) to ensure they are kept securely. Backups are regularly rotated and the old data is permanently deleted. We have a clear internal data handling policy, restricting access to the data and backups to key employees only. In case of a data breach, we will report the breach to the affected users, and to the press/journal contacts within 72 hours.

How do we use the data?

Personal information is only used to deliver the services provided by the publisher. Personal data is not shared externally except for author names, affiliations, emails, and links to ORCiD and social media accounts (if provided) in published articles and books which are displayed as part of the article/book and shared externally to indexes and databases. If a journal operates under open peer review then the reviewer details are published alongside the reviewer details.

How we collect and use your data:

1. When using the website

1.1 what data we collect

  • When you browse our website, we collect anonymised data about your use of the website; for example, we collect information about which pages you view, which files you download, what browser you are using, and when you were using the site.
  • When you comment on an article or book using Disqus, we are not collecting, controlling or processing the data. More details on the DISQUS privacy policy can be found on their website.
  • When you annotate an article or book, this is done via a 3rd party plugin to the website called Hypothes.is. In using this plugin we are not collecting, controlling or processing the data. More details on the Hypothes.is privacy policy can be found on their website.

1.2 why we collect the data

  • We use anonymised website usage data to monitor traffic, help fix bugs, and see overall patterns that inform future redesigns of the website, and provide reports on how frequently the publications on our site have been accessed from within their IP ranges.

1.3 what we do (and don’t do) with the data

  • We do not collect personal information that can be used to identify you when you browse the website.
  • We currently use Google Analytics for publication reports, and to improve the website and services through traffic analysis, but no personal identifying data is shared with Google (for example your computer’s IP is anonymised before transmission).

1.4 what to do if you want to get a copy of your data, or want your data to be removed

  • Please contact info@ubiquitypress.com to request a copy of your data, or for your data to be removed/anonymised.

2. When registering as an author, and submitting an article or book

2.1 what data we collect

  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • As part of submitting an article for publication, you will need to provide personally identifying information which will be used for the peer review process, and will be published. This can include ‘Affiliation’, ‘Competing interests’, ‘Acknowledgements’.

2.2 why we collect the data

  • Registering an account allows you to log in, manage your profile, and participate as an author/reviewer/editor. We use cookies and session information to streamline your use of the website (for example in order for you to remain logged-in when you return to a journal). You can block or delete cookies and still be able to use the websites, although if you do you will then need to enter your username and password to login. In order to take advantage of certain features of the websites, you may also choose to provide us with other personal information, such as your ORCiD, but your decision to utilize these features and provide such data will always be voluntary.
  • Personal data submitted with the article or book is collected to allow follow good publication ethics during the review process, and will form part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.3 what we do (and don’t do) with the data

  • We do not share your personal information with third parties, other than as part of providing the publishing service.
  • As a registered author in the system you may be contacted by the journal editor to submit another article.
  • Any books published on the platform are freely available to download from the publisher website in PDF, EPUB and MOBI formats on the publisher’s site.
  • Any personal data accompanying an article or a book (that will have been added by the submitting author) is published alongside it. The published data includes the names, affiliations and email addresses of all authors.
  • Any articles published on the platform are freely available to download from the publisher website in various formats (e.g. PDF, XML).
  • Ubiquity Press books and articles are typeset by SiliconChips and Diacritech.This process involves them receiving the book and book associated metadata and contacting the authors to finalise the layout. Ubiquity Press work with these suppliers to ensure that personal data is only used for the purposes of typesetting and proofing.
  • For physical purchases of books on the platform Ubiquity Press use print on demand services via Lightning Source who are responsible for printing and distribution via retailers. (For example; Amazon, Book Repository, Waterstones). Lightning Source’s privacy policy and details on data handling can be found on their website.

2.4 why we store the data

  • We store the account data so that you may choose to become a reviewer and be able to perform those tasks, or to become an author and submit an article and then track progress of that article.
  • Published personal data that accompanies an article or a book forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.5 what to do if you want to get a copy of your data, or want your data to be removed

  • You are able to view, change and remove your data associated with your profile. Should you choose to completely delete your account, please contact us at support@ubiquitypress.com and we will follow up with your request as soon as possible.
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

3. When registering as a reviewer

3.1 what data we collect

  • To become a reviewer you must first register as a user on the website, and set your preference that you would like to be considered as a reviewer. No new personal data is collected when a registered user elects to become a reviewer.
  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • Reviewers can also be registered by editors who invite them to review a specific article. This requires the editor to provide the reviewer’s First Name, Last Name, and Email address. Normally this will be done as part of the process of inviting you to review the article or book.
  • On submitting a review, the reviewer includes a competing interest statement, they may answer questions about the quality of the article, and they will submit their recommendation.

3.2 why we collect the data

  • The data entered is used to invite the reviewer to peer review the article or book, and to contact the reviewer during and the review process.
  • If you submit a review then the details of your review, including your recommendation, your responses to any review form, your free-form responses, your competing interests statement, and any cover letter are recorded.

3.3 what we do (and don’t do) with the data

  • This data is not shared publicly and is only accessible by the Editor and system administrators of that journal or press.
  • The data will only be used in connection with that journal or press.
  • Data that is retained post final decision is kept to conform to publication ethics and best practice, to provide evidence of peer review, and to resolve any disputes relating to the peer review of the article or book.
  • For journals or presses that publish the peer reviews, you will be asked to give consent to your review being published, and a subset of the data you have submitted will become part of the published record.

3.4 what to do if you want to get a copy of your data, or want your data to be removed

  • If you would no longer like to be registered as a reviewer you can edit your profile and tick the box ‘stop being a reviewer’. This will remove you from the reviewer database, however any existing reviews you may have carried out will remain.
  • If you have been contacted by an editor to peer review an article this means that you have been registered in the system. If you would not like to be contacted for peer review you can reply to the email requesting that your data be deleted.

4. When being registered as a co-author

4.1 what data we collect

  • Co-author data is entered by the submitting author. The submitting author will already have a user account. According to standard publishing practice, the submitting author is responsible for obtaining the consent of their co-authors to be included (including having their personal data included) in the article/book being submitted to the journal/press.
  • The requested personal data for co-authors are at the bare minimum; first name, last name, institution, country, email address. This can also include; ORCID ID, Title, Middle Name, Biographical Statement, Department, Twitter Handle, Linkedin Profile Name or ImpactStory ID.

4.2 why we collect the data

  • Assuming that it is accepted for publication, this data forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.
  • Author names, affiliations and emails are required for publication and will become part of the permanent cited record.

4.3 what we do (and don’t do) with the data

  • The co-author’s personal data is stored in the author database. This personal data is only used in relation to the publication of the associated article.
  • Any co-author data collected is added to the author database and is only used in association with the article the user is co-author on.

4.5 what to do if you want to get a copy of your data, or want your data to be removed

  • To receive a copy of your data, please contact info@ubiquitypress.com
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

5. When signing-up to receive newsletters

5.1 what data we collect

  • We require you to include your name and email address

5.2 why we collect and store the data, and for how long

  • This data would be collected to keep you updated with any news about the platform or specific journal

5.3 what we do (and don’t do) with the data

  • We use mailchimp to provide our mailing list services. Their privacy policy can be found here

5.4 what to do if you want to get a copy of your data or want your data to be removed

  • All emails sent via our newsletter client will include a link that will allow you to unsubscribe from the mailing list

Notification about change of ownership or of control of data

We may choose to buy or sell assets. In the case that control of data changes to or from Ubiquity Press and a third party, or in the case of change of ownership of Ubiquity Press or of part of the business where the control of personal data is transferred, we will do our best to inform all affected users and present the options.

(Updated: 14th June 2022)